A weekly summary of insider trading highlighting a few notable buying and selling by investors, directors and executives. The ...
Exelixis, Inc. (NASDAQ:EXEL) authorized repurchasing up to an additional $500 million of the company’s common stock before December 31, 2025. Exelixis plans to complete the $500 million stock ...
Two short years ago was a dark time for U.S. financial markets as the Federal Reserve’s crusade against inflation resulted in a record destruction of wealth. In 2022, U.S. stocks had their worst ...
Hosted on MSN21h
Banned Words at FDA; Top Cancer Center Halts DEI Initiatives; 'End Childhood Cancer'"Woman," "elderly," and "disabled" were among a list of banned words reportedly circulating within the FDA, which the White ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback